 |
|
|
| |
The Real-World Israeli experience of treating chronic hepatitis C (CHC), genotype 1 (GT1) patients with advanced fibrosis with paritaprevir/ritonavir/ombitasvir, dasabuvir with or without ribavirin (3D±R): a large multi-center cohort
|
| |
| |
Reported by Jules Levin
EASL 2016 Barcelona April 14-17
Eli Zuckerman, Eyal Ashkenasi, Yulia Kovalev, Ella Weitzman,
Ran Tur-Kaspa, Marius Brown, Michal Cohen, Tarek Saadi,
Yaakov Baruch, Matthias Carlebach, Rawi Hazzan, Rifaat Safadi,
Tova Goldberg, Ran Oren,Yafa Ashur, Michal Carmiel, Yona Kitayi,
Ruth Hadari, Seif Abu-Mouch, Rafael Bruk, Yoram Menachem,
Helena Kathcman, Oren Shibolet
|
| |
|
|
|
|
|
